Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack W Coburn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Kidney International. Supplement|October 9, 2003
An update on vitamin D as related to nephrology practice: 2003Jack W Coburn
Kidney International. Supplement|May 20, 2003
Use of active vitamin D sterols in patients with chronic kidney disease, stages 3 and 4Jack W Coburn, Hla M Maung
Kidney International. Supplement|May 2, 2002
The calcimimetic agents: perspectives for treatmentJoão M Frazão, Patrícia Martins, Jack W Coburn
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 29, 2005
Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysisChaim Charytan, Jack W Coburn, Michel Chonchol, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2004
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4Jack W Coburn, Hla M Maung, Logan Elangovan, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2002
The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidismWilliam G Goodman, Gerald A Hladik, Stewart A Turner, et al.
Kidney International|December 11, 2002
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidismJill S Lindberg, Sharon M Moe, William G Goodman, et al.
Journal of the American Society of Nephrology : JASN|February 4, 2005
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter studyJill S Lindberg, Bruce Culleton, Gordon Wong, et al.
Kidney International|January 28, 2005
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HClSharon M Moe, Glenn M Chertow, Jack W Coburn, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Kidney International. Supplement|October 9, 2003
An update on vitamin D as related to nephrology practice: 2003Jack W Coburn
Kidney International. Supplement|May 20, 2003
Use of active vitamin D sterols in patients with chronic kidney disease, stages 3 and 4Jack W Coburn, Hla M Maung
Kidney International. Supplement|May 2, 2002
The calcimimetic agents: perspectives for treatmentJoão M Frazão, Patrícia Martins, Jack W Coburn
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 29, 2005
Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysisChaim Charytan, Jack W Coburn, Michel Chonchol, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2004
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4Jack W Coburn, Hla M Maung, Logan Elangovan, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2002
The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidismWilliam G Goodman, Gerald A Hladik, Stewart A Turner, et al.
Kidney International|December 11, 2002
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidismJill S Lindberg, Sharon M Moe, William G Goodman, et al.
Journal of the American Society of Nephrology : JASN|February 4, 2005
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter studyJill S Lindberg, Bruce Culleton, Gordon Wong, et al.
Kidney International|January 28, 2005
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HClSharon M Moe, Glenn M Chertow, Jack W Coburn, et al.
Pageof 1